CDC study confirms vaccination’s greater protection against COVID-19 compared to prior infection and natural immunity

Aug 06, 2021 - 08:07 AM
cdc-update

The Centers for Disease Control and Prevention today released a study confirming the comparative effectiveness of COVID-19 vaccines versus natural immunity, including immunity gained from prior SARS-CoV-2 infection. Researchers found that, among hundreds of Kentucky residents with previous infections through June 2021, those who were unvaccinated had 2.34 times the odds of reinfection compared with those who were fully vaccinated. CDC says the research suggests that among people who have had COVID-19 previously, getting fully vaccinated provides additional protection against reinfection.

A second CDC study, published concurrently, shows the extent to which vaccines prevented COVID-19-related hospitalizations among the highest risk age groups.
 

Related News Articles

Headline
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
Olympus recalls endoscope needles
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
ACIP recommends patients consult their provider for COVID-19 vaccine
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…